Tampa, FL (PRWEB) May 04, 2013

World Stem Cells Clinic in Cancun is pleased to announce the appointment of Dr. Ernesto Gutierrez to the position of President of their medical lab and treatment center. Dr. Gutierrez brings experience and intensity to his new position at World Stem Cells Clinic and promises he and his team of experts will provide the best medical care available in the world to improve their patients quality of life.

Dr. Ernesto Gutierrez is an extensively educated physician. He is a graduate from the Universidad Anhuac Norte, School of Medicine in Mexico City and additionally holds a Post-Graduate Degree in Aesthetic and Anti-Aging Medicine from the Instituto Mexicano de Medicina Antienvejecimiento y Esttica, Guadalajara, Mexico. He holds active membership of both the Mexican College of Aesthetic and Anti-Aging Medicine and the Age Management Medicine Group. Dr. Gutierrez has spent considerable time in additional training in the US, with rotations in both Florida and Nevada for two specialty organizations and is certified in Age Management Medicine by the Cenegenics Education and Research Foundation part of Cenegenics Medical Institute in Las Vegas, Nevada. His bilingual English and Spanish skills, both in medical and conversational applications, are excellent. Dr. Gutierrez is the perfect addition to the team given his thorough understanding of both the North and South American medical systems.

Dr. Ernesto Gutierrez explains how the clinic and laboratory at World Stem Cells Clinic in Cancun were designed, built and are operated under the stringent guidelines as established by The International Cellular Medical Society (ICMS) and the US Food and Drug Administrations Good Tissue Practice (cGTP) regulations for pharmaceutical, biologics and clinical laboratories. The strict adherence to these established guidelines and policies guarantees the highest quality of clinical care and stem cell treatment safety for the patient. At World Stem Cells Clinic they continually strive to improve the patients outcomes with breakthrough research and by creating new cells and protocols.

Both the US patient management team at World Stem Cells, LLC (http://worldstemcells.com/) and their Cancun patient management team at World Stem Cells Clinic (http://worldstemcellsclinic.com/) offer medical information on the stem cell treatments provided by the doctors, help patients arrange transportation to Cancun and within the city, hotels, medical records procurement, and basically ensure that their every need is met.

Dr. Gutierrez says, "we will treat you like family!"

Working under the guidelines set forth by ICMS, World Stem Cells Clinic (http://worldstemcellsclinic.com/) provides Stem Cell Treatment for Ankylosing Spondylitis, Autism, Cerebral Palsy, Charcot-Marie-Tooth Disease (CMT), Crohns Diseases, COPD, Fuchs disease, Guillain-Barre Syndrome, Hashimotos Thryroiditis, ITP, Kidney Diseases, Macular Degeneration, Lupus (SLE), Multiple Sclerosis, PAD, Parkinsons disease, Rheumatoid Arthritis, Scleroderma, Stroke, Ulcerative Colitis at its contract Clinics, GLP laboratory, doctors and hospitals in the beautiful resort area of Cancun. They endeavor to provide the best care possible at a competitive price while providing documentation of all treatments that can be used to provide better future care and scientific data to the medical industry. World Stem Cells Clinic is participating in ICMS (International Cellular Medical Society) Stem Cell Reimplantation Registry. They provide Stem Cell Treatments to patients in need.

Go here to read the rest:
Dr. Ernesto Gutierrez is Named President of World Stem Cells Clinic, a Stem Cell Research and Stem Cell Treatment ...

Windpipe grown from stem cells

Lindsey Tanner (AP) / 4 May 2013

A2-year-old girl born without a windpipe now has a new one grown from her own stem cells, the youngest patient in the world to benefit from the experimental treatment.

Hannah Warren has been unable to breathe, eat, drink or swallow on her own since she was born in South Korea in 2010. Until the operation at a US hospital, she had spent her entire life in a hospital in Seoul. Doctors there told her parents there was no hope and they expected her to die.

The stem cells came from Hannahs bone marrow, extracted with a special needle inserted into her hip bone. They were seeded in a lab onto a plastic scaffold, where it took less than a week for them to multiply and create a new windpipe.

The windpipe was implanted on April 9 in a nine-hour procedure.

Early signs indicate the windpipe is working, Hannahs doctors announced, although she is still on a ventilator. They believe she will eventually be able to live at home and lead a normal life.

We feel like shes reborn, said Hannahs father, Darryl Warren.

They hope that she can do everything that a normal child can do but its going to take time. This is a brand new road that all of us are on, he said in a telephone interview. This is her only chance but shes got a fantastic one and an unbelievable one.

Warren choked up and his wife, Lee Young-mi, was teary-eyed at a hospital news conference. Hannah did not attend because she is still recovering from the surgery. She developed an infection after the operation but now is acting like a healthy 2-year-old, her doctors said.

Go here to read the rest:
Windpipe grown from stem cells

Public release date: 2-May-2013 [ | E-mail | Share ]

Contact: John Ascenzi Ascenzi@email.chop.edu 267-426-6055 Children's Hospital of Philadelphia

Medical researchers have manipulated human stem cells into producing types of brain cells known to play important roles in neurodevelopmental disorders such as epilepsy, schizophrenia and autism. The new model cell system allows neuroscientists to investigate normal brain development, as well as to identify specific disruptions in biological signals that may contribute to neuropsychiatric diseases.

Scientists from The Children's Hospital of Philadelphia and the Sloan-Kettering Institute for Cancer Research led a study team that described their research in the journal Cell Stem Cell, published online today.

The research harnesses human embryonic stem cells (hESCs), which differentiate into a broad range of different cell types. In the current study, the scientists directed the stem cells into becoming cortical interneuronsa class of brain cells that, by releasing the neurotransmitter GABA, controls electrical firing in brain circuits.

"Interneurons act like an orchestra conductor, directing other excitatory brain cells to fire in synchrony," said study co-leader Stewart A. Anderson, M.D., a research psychiatrist at The Children's Hospital of Philadelphia. "However, when interneurons malfunction, the synchrony is disrupted, and seizures or mental disorders can result."

Anderson and study co-leader Lorenz Studer, M.D., of the Center for Stem Cell Biology at Sloan-Kettering, derived interneurons in a laboratory model that simulates how neurons normally develop in the human forebrain.

"Unlike, say, liver diseases, in which researchers can biopsy a section of a patient's liver, neuroscientists cannot biopsy a living patient's brain tissue," said Anderson. Hence it is important to produce a cell culture model of brain tissue for studying neurological diseases. Significantly, the human-derived cells in the current study also "wire up" in circuits with other types of brain cells taken from mice, when cultured together. Those interactions, Anderson added, allowed the study team to observe cell-to-cell signaling that occurs during forebrain development.

In ongoing studies, Anderson explained, he and colleagues are using their cell model to better define molecular events that occur during brain development. By selectively manipulating genes in the interneurons, the researchers seek to better understand how gene abnormalities may disrupt brain circuitry and give rise to particular diseases. Ultimately, those studies could help inform drug development by identifying molecules that could offer therapeutic targets for more effective treatments of neuropsychiatric diseases.

In addition, Anderson's laboratory is studying interneurons derived from stem cells made from skin samples of patients with chromosome 22q.11.2 deletion syndrome, a genetic disease which has long been studied at The Children's Hospital of Philadelphia. In this multisystem disorder, about one third of patients have autistic spectrum disorders, and a partially overlapping third of patients develop schizophrenia. Investigating the roles of genes and signaling pathways in their model cells may reveal specific genes that are crucial in those patients with this syndrome who have neurodevelopmental problems.

See original here:
Turning human stem cells into brain cells sheds light on neural development